APVO logo

Aptevo Therapeutics (APVO)

Profile

Full Name

Aptevo Therapeutics Inc.

Ticker Symbol

APVO

Exchange

NASDAQ

Country

United States

IPO

July 20, 2016

Indexes

Not included

Employees

37

Key Details

Price

$1.04(+2.97%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$87.38(+96.23% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

May 13, 22 Piper Sandler
Overweight
May 28, 21 Roth Capital
Buy
Nov 25, 20 Roth Capital
Buy
Nov 25, 20 PiperJaffray
Overweight
Nov 11, 20 Piper Sandler
Overweight
Apr 11, 18 Roth Capital
Buy
Sep 9, 16 Piper Sandler
Overweight

Institutional Ownership

  • What is the ticker symbol for Aptevo Therapeutics?
  • Does Aptevo Therapeutics pay dividends?
  • What sector is Aptevo Therapeutics in?
  • What industry is Aptevo Therapeutics in?
  • What country is Aptevo Therapeutics based in?
  • When did Aptevo Therapeutics go public?
  • Is Aptevo Therapeutics in the S&P 500?
  • Is Aptevo Therapeutics in the NASDAQ 100?
  • Is Aptevo Therapeutics in the Dow Jones?
  • When was Aptevo Therapeutics's last earnings report?
  • When does Aptevo Therapeutics report earnings?
  • Should I buy Aptevo Therapeutics stock now?

What is the ticker symbol for Aptevo Therapeutics?

The ticker symbol for Aptevo Therapeutics is NASDAQ:APVO

Does Aptevo Therapeutics pay dividends?

No, Aptevo Therapeutics does not pay dividends

What sector is Aptevo Therapeutics in?

Aptevo Therapeutics is in the Healthcare sector

What industry is Aptevo Therapeutics in?

Aptevo Therapeutics is in the Biotechnology industry

What country is Aptevo Therapeutics based in?

Aptevo Therapeutics is headquartered in United States

When did Aptevo Therapeutics go public?

Aptevo Therapeutics's initial public offering (IPO) was on July 20, 2016

Is Aptevo Therapeutics in the S&P 500?

No, Aptevo Therapeutics is not included in the S&P 500 index

Is Aptevo Therapeutics in the NASDAQ 100?

No, Aptevo Therapeutics is not included in the NASDAQ 100 index

Is Aptevo Therapeutics in the Dow Jones?

No, Aptevo Therapeutics is not included in the Dow Jones index

When was Aptevo Therapeutics's last earnings report?

Aptevo Therapeutics's most recent earnings report was on Feb 14, 2025

When does Aptevo Therapeutics report earnings?

The next expected earnings date for Aptevo Therapeutics is May 8, 2025

Should I buy Aptevo Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page